uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys
INSERM U1070, Pole Biol Sante, F-86073 Poitiers 9, France.;Univ Poitiers, Fac Med & Pharm, F-86073 Poitiers 9, France.;CHU Poitiers, Lab Toxicol & Pharmacocinet, F-86000 Poitiers, France..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Univ Tours, Ctr Etude Pathol Resp, Fac Med, INSERM UMR EA6305 1100, F-37032 Tours, France..
Univ Tours, Ctr Etude Pathol Resp, Fac Med, INSERM UMR EA6305 1100, F-37032 Tours, France..
Show others and affiliations
2015 (English)In: Pharmaceutical research, ISSN 0724-8741, E-ISSN 1573-904X, Vol. 32, no 10, 3403-3414 p.Article in journal (Refereed) Published
Abstract [en]

The objective of this study was to compare two different nebulizers: Eflow rapidA (R) and Pari LC starA (R) by scintigraphy and PK modeling to simulate epithelial lining fluid concentrations from measured plasma concentrations, after nebulization of CMS in baboons. Three baboons received CMS by IV infusion and by 2 types of aerosols generators and colistin by subcutaneous infusion. Gamma imaging was performed after nebulisation to determine colistin distribution in lungs. Blood samples were collected during 9 h and colistin and CMS plasma concentrations were measured by LC-MS/MS. A population pharmacokinetic analysis was conducted and simulations were performed to predict lung concentrations after nebulization. Higher aerosol distribution into lungs was observed by scintigraphy, when CMS was nebulized with Pari LCA (R) star than with Eflow RapidA (R) nebulizer. This observation was confirmed by the fraction of CMS deposited into the lung (respectively 3.5% versus 1.3%).CMS and colistin simulated concentrations in epithelial lining fluid were higher after using the Pari LC starA (R) than the Eflow rapidA (R) system. A limited fraction of CMS reaches lungs after nebulization, but higher colistin plasma concentrations were measured and higher intrapulmonary colistin concentrations were simulated with the Pari LC StarA (R) than with the Eflow RapidA (R) system.

Place, publisher, year, edition, pages
2015. Vol. 32, no 10, 3403-3414 p.
Keyword [en]
colistin, nebulization, pharmacokinetic modelling, scintigraphy
National Category
Pharmacology and Toxicology
URN: urn:nbn:se:uu:diva-264832DOI: 10.1007/s11095-015-1716-0ISI: 000361720700023PubMedID: 26040660OAI: oai:DiVA.org:uu-264832DiVA: diva2:861868
Available from: 2015-10-19 Created: 2015-10-19 Last updated: 2015-10-19Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Bouchene, Salim
By organisation
Department of Pharmaceutical Biosciences
In the same journal
Pharmaceutical research
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 183 hits
ReferencesLink to record
Permanent link

Direct link